Results 51 to 60 of about 6,247 (199)

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source

Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction

ESC Heart Failure, 2023
Aims Heart failure with mildly reduced ejection fraction (HFmrEF) has received increasing attention following the publication of the latest ESC guidelines in 2021.
Xinxin Zhang, Yuxi Sun, Yunlong Zhang, Ning Wang, Qiuyan Sha, Songqi Yu, Xin Lv, Zijie Ding, Yanli Zhang, Gary Tse, Ying Liu   +10 more
doaj   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry. [PDF]

, 2002
AIMS: To perform a comprehensive characterization of acute heart failure (AHF) with preserved (HFpEF), versus mildly reduced (HFmrEF) versus reduced ejection fraction (HFrEF).
Coats, AJS, Mitja Lainscak, Drozdz, Jaroslaw, Savarese, G, Lainscak, Mitja, Filippatos, Gerasimos, Andrew J.S. Coats, Piepoli, M, Mebazaa, A, McDonagh, Theresa, Maria G. Crespo‐Leiro, Rosano, Giuseppe M. C., Lainscak, M, Rosano, Giuseppe M.C., Hage, C, Kapłon-Cieślicka, A, Gianluigi Savarese, Anker, SD, Jarosław Drożdż, Ruschitzka, Frank, Theresa McDonagh, Savarese, Gianluigi, Ovidiu Chioncel, Lars H. Lund, on behalf of the Heart Failure Association (HFA) of the European, Petar Seferovic, Anker, Stefan D., Crespo-Leiro, MG, Lund, Lars H., Hage, Camilla, Camilla Hage, Chioncel, Ovidiu, Maggioni, Aldo P., Anker, Stefan, Mebazaa, Alexandre, Lina Benson, Rosano, GMC, Filippatos, G, Ruschitzka, F, McDonagh, T, Coats, Andrew J.S., Benson, L, Massimo Piepoli, Crespo-Leiro, Maria G., Gerasimos Filippatos, Frank Ruschitzka, Lund, LH, Benson, Lina, Stefan D. Anker, Crespo-Leiro, María Generosa, Piepoli, Massimo, Agnieszka Kapłon‐Cieślicka, Ferrari, Roberto, Drożdż, J, Alexandre Mebazaa, Coats, Andrew J. S., Kaplon-Cieslicka, Agnieszka, Roberto Ferrari, Seferovic, Petar, Maggioni, AP, Chioncel, O, Seferovic, P, Ferrari, R, Giuseppe M.C. Rosano, Aldo P. Maggioni   +64 more
core   +3 more sources

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition

Cardiac Failure Review, 2020
The recent definition of an intermediate clinical phenotype of heart failure (HF) based on an ejection fraction (EF) of between 40% and 49%, namely HF with mid-range EF (HFmrEF), has fuelled investigations into the clinical profile and prognosis of this ...
Davide Margonato, Simone Mazzetti, Renata De Maria, Marco Gorini, Massimo Iacoviello, Aldo P Maggioni, Andrea Mortara   +6 more
doaj   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Cardiovascular death risk in recovered mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test [PDF]

, 2020
Background: Heart failure with midrange ejection fraction (HFmrEF) represents a heterogeneous category where phenotype, as well as prognostic assessment, remains still debated.
Magrì D, Lenarda AD, BADAGLIACCA R., SCIOMER S., PARATI G., Scardovi AB, GUAZZI M., METRA M., SINAGRA G., CORREALE M., Gallo G, Girola D, SCRUTINIO D., Senni M, Passino C, AGOSTONI P., LOMBARDI C., Sinagra G, FRIGERIO M., Agostoni P, Paolillo S, MAGGIONI A. L. D. O., LAGIOIA R., GIROLA D., Guazzi M, Vignati C, PIEPOLI M., DI LENARDA A., Corrà U, CLEMENZA F., PASSINO C., CICOIRA M., VOLPE M., Mapelli M, Piepoli M, Frigerio M, Bussotti M, PAOLILLO S., Correale M, BUSSOTTI M., MAGRI D., SENNI M., Lagioia R, Limongelli G, MARUOTTI A., EMDIN M., Badagliacca R, MAPELLI M., Salvioni E, Cattadori G, Cicoira M, PERRONE FILARDI P., Metra M, Lombardi C, Maggioni A, Parati G, Emdin M, CORRA U. G. O., Clemenza F, SALVIONI E., Maruotti A, CATTADORI G. A. I. A., LIMONGELLI G., Filardi PP, VIGNATI C., Sciomer S, Volpe M, Scrutinio D, GALLO G., SCARDOVI A. B.   +69 more
core   +3 more sources

Correlation of NT-proBNP Levels with Outcome in Patients of Acute Decompensated Heart Failure

Indian Journal of Medical Specialities
Background: Acute decompensated heart failure (ADHF) is a significant contributor to morbidity and mortality globally, particularly in resource-limited settings like India.
Dheeraj Balotia, Anshuman Srivastava, Amitesh Aggarwal, Alpana Raizada, Rahul Sharma   +4 more
doaj   +1 more source